Transition of Power

How Trump’s Choice to Lead FDA Aligns With RFK Jr.’s Views on Health and Transparency

RFK Jr. and Marty Makary are both critics of COVID-19 mandates and advocates for removing chemicals and toxins from America’s food supply.
How Trump’s Choice to Lead FDA Aligns With RFK Jr.’s Views on Health and Transparency
Dr. Marty Makary, surgeon, professor at Johns Hopkins University, and author of “Blind Spots: What Medicine Gets Wrong, and What It Means for Our Health,” gives an interview on EpochTV's "American Thought Leaders" on Sept. 17, 2024.
Jeff Louderback
|Updated:
0:00

Dr. Marty Makary, President-elect Donald Trump’s choice to lead the Food and Drug Administration (FDA), and Robert F. Kennedy Jr., his nominee to head the Department of Health and Human Services (HHS), are both critics of COVID-19 mandates, advocates for removing chemicals and toxins from America’s food supply, and proponents of greater transparency in medicine.

If both men are confirmed by the Senate in January 2025, Kennedy will serve as Makary’s boss, as the FDA is one of 13 agencies under HHS.

Jeff Louderback
Jeff Louderback
Reporter
Jeff Louderback covers news and features on the White House and executive agencies for The Epoch Times. He also reports on Senate and House elections. A professional journalist since 1990, Jeff has a versatile background that includes covering news and politics, business, professional and college sports, and lifestyle topics for regional and national media outlets.